News Releases

Month Year

Month Year

Feb 16, 2017

Insmed to Host Fourth Quarter and Year-end 2016 Financial Results Conference Call on Thursday, February 23, 2017
Feb 14, 2017

Insmed Inc. Extends ARIKAYCE Intellectual Property Protection with Issuance of New U.S. Patent
Jan 4, 2017

Insmed to Present at the 35th Annual J.P. Morgan Healthcare Conference
Nov 14, 2016

Insmed to Participate at November Investor Conferences
Nov 3, 2016

Insmed Reports Third Quarter 2016 Financial Results and Provides Business Update

Enrollment objective achieved in phase 3 CONVERT study
Oct 27, 2016

Insmed to Host Third Quarter 2016 Financial Results Conference Call on Thursday, November 3, 2016
Oct 18, 2016

Insmed Announces Publication of Phase 2 Study of ARIKAYCE in Treatment-Refractory Nontuberculous Mycobacterial Lung Disease

Data in American Journal of Respiratory and Critical Care Medicine demonstrate ARIKAYCE's potential to achieve early and sustained negative sputum cultures
Oct 5, 2016

Insmed Announces Worldwide License Agreement with AstraZeneca for Oral DPP1 Inhibitor
Sep 27, 2016

Insmed Appoints Roger Adsett as Chief Commercial Officer
Sep 8, 2016

Insmed to Participate at September Investor Conferences

Show per page

Stay In The Loop

Want to stay up to date on our news, events, and filings? Set up your
email alerts.

View the latest Insmed Investor Presentation